Next, we asked whether there is clinical relevance between the proportion of IL-8+ naïve T cells and clinicopathological features, including WHO subtypes, Masaoka stages, the presence of MG and tumor sizes, in patients with thymomas. This evidence concerns the gene CXCL8 and thymoma.